EnPlusOne to Unveil Advances in Enzymatic RNA Synthesis at TIDES 2024

EnPlusOne Biosciences, Inc., a biotechnology company harnessing the power of enzymes to deliver sustainable RNA at scale, today announced that co-founder and Chief Scientific Officer Jonathan Rittichier, PhD, will be presenting recent advances in the company’s ezRNA™ platform at TIDES USA 2024 in Boston on Thursday, May 16, 2024 at 9am. The three day event, at the Hynes Convention Center, brings together scientists and companies focused on the use of oligonucleotides and peptides in therapeutics.